Literature DB >> 17692626

Older kidneys donor transplantation: five years' experience without biopsy and using clinical laboratory and macroscopic anatomy evaluation.

M Santangelo1, M Zuccaro, P De Rosa, V Tammaro, S Grassia, S Federico, A L Ciotola, G Spinosa, A Renda.   

Abstract

INTRODUCTION: The exponential increase in organ demand is not associated with a similar increase of available kidneys. This emergency led to expanded criteria to consider a kidney transplantable. The aim of this retrospective study was to explain our use of older donor kidneys without biopsy.
MATERIALS AND METHODS: Between 2000 and 2005, 58 older kidneys were harvested: 27 were transplanted in our center; 13 were discarded; and 18 were transplanted in other centers. We considered 3 factors to define kidney quality: macroscopic anatomy, multiple factors linked to the donor, and clinical-laboratory data. After transplantation, we observed the patients for at least 1 year and up to 6 years. DISCUSSION: At 1 year, 24/27 (89%) patients had a functional kidney, 2 patients showed an initial renal failure and 1 patient lost the kidney. At maximum follow-up, 19 patients (70%) had functional kidneys, 4 with initial renal failure. These results compared with the kidneys harvested using Standard Donor Kidney Criteria are acceptable. Obviously we need long-term follow-up to increase, the amount of data and obtain a definitive outcome.
CONCLUSION: Biopsy is the gold standard for the definition of an older kidney's quality. When a biopsy is not feasible, the study of the macroscopic anatomy the kidney's donor and of some donor's parameters represent an acceptable biopsy alternative, being able to rescue some organs that would be otherwise lost.

Entities:  

Mesh:

Year:  2007        PMID: 17692626     DOI: 10.1016/j.transproceed.2007.05.039

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Can only histological evaluation determine the allocation of ECD kidneys?

Authors:  Carlo Grifasi; Vincenzo D'Alessandro; Maria D'Armiento; Severo Campione; Alessandro Scotti; Luigi Pelosio; Andrea Renda
Journal:  BMC Nephrol       Date:  2014-12-23       Impact factor: 2.388

2.  Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study.

Authors:  Michele L Santangelo; Carmen Criscitiello; Andrea Renda; Stefano Federico; Giuseppe Curigliano; Concetta Dodaro; Alessandro Scotti; Vincenzo Tammaro; Armando Calogero; Eleonora Riccio; Antonio Pisani; Nicola Carlomagno
Journal:  Biomed Res Int       Date:  2015-06-22       Impact factor: 3.411

3.  Kidney Transplantation from an extracorporeal membrane oxygenation-supported brain-dead donor: A case report.

Authors:  Pei-Jhang Chiang; Shou-Hung Tang; Chiao-Ching Li; Meng-Han Chou; Yu-Chun Lin; Sheng-Tang Wu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 4.  Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients.

Authors:  Armando Calogero; Evangelista Sagnelli; Massimiliano Creta; Silvia Angeletti; Gaia Peluso; Paola Incollingo; Maria Candida; Gianluca Minieri; Nicola Carlomagno; Concetta Anna Dodaro; Massimo Ciccozzi; Caterina Sagnelli
Journal:  Biomed Res Int       Date:  2019-04-07       Impact factor: 3.411

5.  COVID-19 and Living Donor Kidney Transplantation in Naples during the Pandemic.

Authors:  Gaia Peluso; Silvia Campanile; Alessandro Scotti; Vincenzo Tammaro; Akbar Jamshidi; Luigi Pelosio; Marcello Caggiano; Teresa Pagano; Francesco Cuozzo; Fabrizio D'Ambrosio; Armando Calogero; Concetta Dodaro; Caterina Sagnelli; Nicola Carlomagno; Michele L Santangelo
Journal:  Biomed Res Int       Date:  2020-10-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.